tiprankstipranks
AstraZeneca’s Promising Growth Driven by Robust Pipeline and Innovative Products
PremiumRatingsAstraZeneca’s Promising Growth Driven by Robust Pipeline and Innovative Products
7d ago
Alexion’s ravulizumab granted FDA orphan designation
Premium
The Fly
Alexion’s ravulizumab granted FDA orphan designation
7d ago
Big pharma fears drug price spikes in US-EU tariff spat, Reuters says
Premium
The Fly
Big pharma fears drug price spikes in US-EU tariff spat, Reuters says
8d ago
AstraZeneca enters license agreement with Alteogen for ALT-B4
PremiumThe FlyAstraZeneca enters license agreement with Alteogen for ALT-B4
9d ago
AstraZeneca’s Promising Pipeline and Attractive Valuation Drive Buy Rating
Premium
Ratings
AstraZeneca’s Promising Pipeline and Attractive Valuation Drive Buy Rating
9d ago
AstraZeneca to acquire EsoBiotec for $425M upfront
Premium
The Fly
AstraZeneca to acquire EsoBiotec for $425M upfront
9d ago
Cellectis reports Q4 EPS (64c) vs (17c) last year
PremiumThe FlyCellectis reports Q4 EPS (64c) vs (17c) last year
12d ago
Capital Group Increases Stake in AstraZeneca
Premium
Company Announcements
Capital Group Increases Stake in AstraZeneca
13d ago
AstraZeneca’s Promising Future: Buy Rating Backed by Robust Pipeline and Strong Sales Potential
Premium
Ratings
AstraZeneca’s Promising Future: Buy Rating Backed by Robust Pipeline and Strong Sales Potential
14d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100